Tekla Life Profit Margin vs. Price To Sales

HQL Stock  USD 14.13  0.21  1.51%   
Based on the measurements of profitability obtained from Tekla Life's financial statements, Tekla Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Tekla Life's ability to earn profits and add value for shareholders.

Tekla Life Net Profit Margin

1.04

Operating Cash Flow Sales Ratio is expected to grow at the current pace this year, although the value of Price To Sales Ratio will most likely fall to 15.52. At this time, Tekla Life's Operating Income is quite stable compared to the past year. Income Tax Expense is expected to rise to about 27 M this year, although the value of Total Other Income Expense Net is projected to rise to (1.9 K).
For Tekla Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tekla Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tekla Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tekla Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tekla Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.425
Dividend Share
1.3
Earnings Share
1.34
Revenue Per Share
0.134
Quarterly Revenue Growth
0.07
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tekla Life Sciences Price To Sales vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tekla Life's current stock value. Our valuation model uses many indicators to compare Tekla Life value to that of its competitors to determine the firm's financial worth.
Tekla Life Sciences is one of the top stocks in profit margin category among its peers. It also is one of the top stocks in price to sales category among its peers fabricating about  70.32  of Price To Sales per Profit Margin. At this time, Tekla Life's Net Profit Margin is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tekla Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Tekla Price To Sales vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Tekla Life

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
1.56 %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Tekla Life

P/S

 = 

MV Per Share

Revenue Per Share

 = 
110.01 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Tekla Price To Sales Comparison

Tekla Life is currently under evaluation in price to sales category among its peers.

Tekla Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tekla Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tekla Life will eventually generate negative long term returns. The profitability progress is the general direction of Tekla Life's change in net profit over the period of time. It can combine multiple indicators of Tekla Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income25.7 M27 M
Income Before Tax25.7 M20.3 M
Total Other Income Expense Net-2 K-1.9 K
Net Income25.7 M19.7 M
Net Income From Continuing Ops20.1 M16 M
Net Loss-94.1 M-89.4 M
Income Tax Expense25.7 M27 M
Interest Income184 K174.8 K
Net Interest Income235.1 K149.8 K
Change To Netincome-127.6 M-121.2 M
Net Income Per Share 0.75  0.77 
Net Income Per E B T 0.90  0.80 

Tekla Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tekla Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tekla Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tekla Life's important profitability drivers and their relationship over time.

Use Tekla Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Life will appreciate offsetting losses from the drop in the long position's value.

Tekla Life Pair Trading

Tekla Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to Tekla Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Life Sciences to buy it.
The correlation of Tekla Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tekla Life position

In addition to having Tekla Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out Risk vs Return Analysis.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
To fully project Tekla Life's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tekla Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tekla Life's income statement, its balance sheet, and the statement of cash flows.
Potential Tekla Life investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Tekla Life investors may work on each financial statement separately, they are all related. The changes in Tekla Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tekla Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.